BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25122166)

  • 1. In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes.
    Rojas-Caraballo J; López-Abán J; Pérez del Villar L; Vizcaíno C; Vicente B; Fernández-Soto P; del Olmo E; Patarroyo MA; Muro A
    PLoS One; 2014; 9(8):e105323. PubMed ID: 25122166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: identification of genes and pathways involved in conferring immunoprotection in a murine model.
    Rojas-Caraballo J; López-Abán J; Moreno-Pérez DA; Vicente B; Fernández-Soto P; Del Olmo E; Patarroyo MA; Muro A
    BMC Infect Dis; 2017 Jan; 17(1):94. PubMed ID: 28114888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
    Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
    J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
    Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
    Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Vaccine Based on Kunitz-Type Molecule Confers Protection Against
    Silvane L; Celias DP; Romagnoli PA; Maletto BA; Sanchez Vallecillo MF; Chiapello LS; Palma SD; Allemandi DA; Sanabria REF; Pruzzo CI; Motrán CC; Cervi L
    Front Immunol; 2020; 11():2087. PubMed ID: 33193292
    [No Abstract]   [Full Text] [Related]  

  • 6. A mucin-like peptide from Fasciola hepatica induces parasite-specific Th1-type cell immunity.
    Noya V; Brossard N; Berasaín P; Rodríguez E; Chiale C; Mazal D; Carmona C; Freire T
    Parasitol Res; 2016 Mar; 115(3):1053-63. PubMed ID: 26637311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.
    Rivera F; Espino AM
    Exp Parasitol; 2016 Jan; 160():31-8. PubMed ID: 26632503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of protective peptides of Fasciola hepatica-derived cathepsin L1 (FhCL1) in vaccinated sheep by a linear B-cell epitope mapping approach.
    Buffoni L; Garza-Cuartero L; Pérez-Caballero R; Zafra R; Javier Martínez-Moreno F; Molina-Hernández V; Pérez J; Martínez-Moreno Á; Mulcahy G
    Parasit Vectors; 2020 Jul; 13(1):390. PubMed ID: 32736582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family.
    Torres D; Espino AM
    Infect Immun; 2006 Aug; 74(8):4932-8. PubMed ID: 16861685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciola hepatica infection downregulates Th1 responses in mice.
    O'Neill SM; Brady MT; Callanan JJ; Mulcahy G; Joyce P; Mills KH; Dalton JP
    Parasite Immunol; 2000 Mar; 22(3):147-55. PubMed ID: 10672196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica.
    Miller CM; Smith NC; Ikin RJ; Boulter NR; Dalton JP; Donnelly S
    PLoS One; 2009 May; 4(5):e5692. PubMed ID: 19478853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive immune stimulation is required to obtain high protection with fatty acid binding protein vaccine candidate against Fasciola hepatica in Balb/C mice.
    López-Abán J; Esteban A; Vicente B; Rojas-Caraballo J; del Olmo E; Martínez-Fernández AR; Hillyer GV; Muro A
    J Parasitol; 2012 Jun; 98(3):527-35. PubMed ID: 22191522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
    López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
    Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a Peptide-Carrier Vaccine Based on the Highly Immunogenic Fasciola hepatica Leucine Aminopeptidase.
    Salazar C; Tort JF; Carmona C
    Methods Mol Biol; 2020; 2137():191-204. PubMed ID: 32399930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats.
    Villa-Mancera A; Reynoso-Palomar A; Utrera-Quintana F; Carreón-Luna L
    Parasitol Res; 2014 Jan; 113(1):243-50. PubMed ID: 24218177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5 kDa saposin-like protein SAP-2 using synthetic peptides.
    Espino AM; Torres D; Morales A; Delgado B; Quetel J; Osuna A
    Exp Parasitol; 2007 Sep; 117(1):65-73. PubMed ID: 17475253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.
    Kesik-Brodacka M; Lipiec A; Kozak Ljunggren M; Jedlina L; Miedzinska K; Mikolajczak M; Plucienniczak A; Legocki AB; Wedrychowicz H
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005451. PubMed ID: 28333957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ex vivo immunoproteomic approach characterising Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep.
    Cameron TC; Cooke I; Faou P; Toet H; Piedrafita D; Young N; Rathinasamy V; Beddoe T; Anderson G; Dempster R; Spithill TW
    Int J Parasitol; 2017 Aug; 47(9):555-567. PubMed ID: 28455238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.